Ipamorelin: What It Is and Its U.S. Regulatory Status

What is ipamorelin?

Ipamorelin is a synthetic peptide made of five amino acids. It belongs to a group called growth hormone secretagogues, which act on the ghrelin receptor and signal the pituitary gland to release growth hormone. It was developed in the 1990s and is described as more selective than earlier compounds in this group.

Ipamorelin has been studied in clinical trials for postoperative ileus, a slowdown of normal bowel function after surgery. It was not approved for that or any other use.

U.S. regulatory status

Current status: Not FDA-approved.

This means the FDA has not approved ipamorelin as safe and effective for any medical use. No product containing it is an approved medicine in the United States.

Growth hormone secretagogues, including ipamorelin, are also prohibited in competitive sport under the World Anti-Doping Code.

Why Peptide Labs does not sell ipamorelin

Peptide Labs does not sell this compound. This page is general information, not medical advice. We do not supply, prepare or distribute ipamorelin in any form, and nothing on this page should be read as an offer.

If you have questions about ipamorelin or a related health concern, talk to a licensed healthcare provider who knows your medical history.

Related reading

See the full list of compound profiles in the Peptide Guide.